V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN) Peptid
Kurzübersicht für V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN) Peptid (ABIN937504)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- DPTSNKQQRP VPESQLLPGQ RFQTKDPEEQ GDIVVALYPY DGIHPDDLSF
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LYN antibody,
Alternative Names: LYN control peptide, LYN antibody Blocking Peptide, Anti-LYN Blocking Peptide, V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog Blocking Peptide, FLJ26625 Blocking Peptide, JTK8 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- LYN (V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN))
-
Hintergrund
- LYN down regulates expression of stem cell growth factor receptor (KIT).LYN acts as an effector of EpoR (erythropoietin receptor) in controlling KIT expression and may play a central role in erythroid differentiation during the switch between proliferation and maturation.
-
Molekulargewicht
- 58 kDa
Target
-